Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases | Patent Number 11491148

US 11491148 B2
Application Number16867249
Publication NumberUS 20200352925 A1
Pendency2 years, 6 months, 7 days
Filled DateMay 5, 2020
Priority DateMay 5, 2020
Publication DateNov 12, 2020
Expiration DateMay 4, 2040
Inventor/ApplicantsChristelle Catherine Cecile Doebelin
Jan Martin Berke
Edgar Jacoby
Bart Rudolf Romanie Kesteleyn
Wim Gaston Verschueren
Michel Obringer
Wim Gaston VERSCHUEREN
Jan Martin BERKE
Tim Hugo Maria Jonckers
Stefaan Julien Last
Michel OBRINGER
Bart Rudolf Romanie KESTELEYN
Sandrine Celine Grosse
Sandrine Celine GROSSE
Edgar JACOBY
Erwin COESEMANS
Erwin Coesemans
Stefaan Julien LAST
Tim Hugo Maria JONCKERS
Christelle Catherine Cecile DOEBELIN
ExaminesMCDOWELL, BRIAN E
Art Unit1624
Technology Center1600
Assignments
Janssen Pharmaceuticals Johnson & Johnson
Current
Janssen Sciences Ireland Unlimited CompanyJohnson & Johnson
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.